Nahad Sedaghat

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Masoud Etemadifar, Nahad Sedaghat, Ali Aghababaee et al. · Multiple Sclerosis and Related Disorders · 2021 · 56 citations · Full text

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient

Masoud Etemadifar, Amirhossein Akhavan Sigari, Nahad Sedaghat et al. · Human Vaccines & Immunotherapeutics · 2021 · 34 citations · Full text

Neurological Disorder, Immunology, Neurological Progress +18

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri et al. · BMC Neurology · 2022 · 26 citations · Full text

SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine

Masoud Etemadifar, Nahad Sedaghat, Hosein Nouri et al. · Multiple Sclerosis and Related Disorders · 2021 · 23 citations · Full text

Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial

Sayed Lotfollah Afzali, Hesam Panahi, Forouzan Ganji et al. · Aesthetic Plastic Surgery · 2021 · 19 citations

Field Quality, Medicine, Patient Safety +10